Avalon Holding Group Inc (AVLH.PK) Quote| Reuters.com
United States

Avalon Holding Group Inc (AVLH.PK)

AVLH.PK on OTC Markets Group - US Other OTC and Grey Market

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for AVLH.PK


AVALON HOLDING GROUP, INC. is a development-stage company. The Company, through its wholly owned subsidiary, Painmaster Products, Inc., intended to license, manufacture, market and distribute, within the United States and Canada, a Micro Current Therapy patch that is drug free, non-invasive and proven to control pain and promote... (more)
No analyst recommendations are available for AVLH.PK.


Beta: --
Market Cap(Mil.): $--
Shares Outstanding(Mil.): 121.32
Dividend: --
Yield (%): --


  AVLH.PK Industry Sector
P/E (TTM): -- 30.50 26.52
EPS (TTM): -0.00 -- --
ROI: -- 9.58 9.18
ROE: -- 11.54 12.21


  Price Chg
Amgen, Inc. (AMGN.OQ) $150.10 +1.68
Gilead Sciences, Inc. (GILD.OQ) $82.27 -0.04
Biogen Inc (BIIB.OQ) $238.91 +10.39
Zogenix, Inc. (ZGNX.OQ) $8.09 +0.20
Novacyt SA (ALNOV.PA) €1.38 -0.01

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.